Subarachnoid hemorrhage pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 23: Line 23:
*[[Cigarette smoking]]  
*[[Cigarette smoking]]  
*[[Connective tissue disease]]  
*[[Connective tissue disease]]  
**Ehlers-Danlos syndrome  
**[[Ehlers-Danlos syndrome]]
**Pseudoxanthoma elasticum
**[[Pseudoxanthoma elasticum]]
The role for '''genetic factors''' in pathogenesis of aneurysmal formation has been approved. However, the exact pathogenesis remains unknown. It is thought that some connective tissue disease may result in  arterial wall weakness and non-laminar flow pattern of blood, which is then progress to tear and breakdown of the wall.<ref name="pmid10706896">{{cite journal| author=Pepin M, Schwarze U, Superti-Furga A, Byers PH| title=Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. | journal=N Engl J Med | year= 2000 | volume= 342 | issue= 10 | pages= 673-80 | pmid=10706896 | doi=10.1056/NEJM200003093421001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10706896  }} </ref><ref name="pmid6864273">{{cite journal| author=Neil-Dwyer G, Bartlett JR, Nicholls AC, Narcisi P, Pope FM| title=Collagen deficiency and ruptured cerebral aneurysms. A clinical and biochemical study. | journal=J Neurosurg | year= 1983 | volume= 59 | issue= 1 | pages= 16-20 | pmid=6864273 | doi=10.3171/jns.1983.59.1.0016 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6864273  }} </ref>
*[[Hyperaldosteronism|Familial aldosteronism type I]]
The role for '''genetic factors''' in pathogenesis of aneurysmal formation has been approved. However, the exact pathogenesis remains unknown. It is thought that some connective tissue disease may result in  arterial wall weakness and non-laminar flow pattern of blood, which is then progress to tear and breakdown of the wall.<ref name="pmid10706896">{{cite journal| author=Pepin M, Schwarze U, Superti-Furga A, Byers PH| title=Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. | journal=N Engl J Med | year= 2000 | volume= 342 | issue= 10 | pages= 673-80 | pmid=10706896 | doi=10.1056/NEJM200003093421001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10706896  }} </ref><ref name="pmid6864273">{{cite journal| author=Neil-Dwyer G, Bartlett JR, Nicholls AC, Narcisi P, Pope FM| title=Collagen deficiency and ruptured cerebral aneurysms. A clinical and biochemical study. | journal=J Neurosurg | year= 1983 | volume= 59 | issue= 1 | pages= 16-20 | pmid=6864273 | doi=10.3171/jns.1983.59.1.0016 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6864273 }} </ref>  Additionally, it is thought concurrent [[hypertension]] may play a role in patient with [[Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease (PKD)]].<ref name="pmid21641282">{{cite journal| author=Vlak MH, Algra A, Brandenburg R, Rinkel GJ| title=Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. | journal=Lancet Neurol | year= 2011 | volume= 10 | issue= 7 | pages= 626-36 | pmid=21641282 | doi=10.1016/S1474-4422(11)70109-0 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21641282 }}</ref>
======Histopathologic findings======
======Histopathologic findings======
Unruptured aneurysms wall may present with complete absence of endothelial lining.  
Unruptured aneurysms wall may present with complete absence of endothelial lining.  

Revision as of 21:57, 5 December 2016

Subarachnoid Hemorrhage Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Subarachnoid Hemorrhage from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

AHA/ASA Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage (2012)

Risk Factors/Prevention
Natural History/Outcome
Clinical Manifestations/Diagnosis
Medical Measures to Prevent Rebleeding
Surgical and Endovascular Methods
Hospital Characteristics/Systems of Care
Anesthetic Management
Cerebral Vasospasm and DCI
Hydrocephalus
Seizures Associated With aSAH
Medical Complications

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Subarachnoid hemorrhage pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Subarachnoid hemorrhage pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Subarachnoid hemorrhage pathophysiology

CDC on Subarachnoid hemorrhage pathophysiology

Subarachnoid hemorrhage pathophysiology in the news

Blogs on Subarachnoid hemorrhage pathophysiology

Directions to Hospitals Treating Subarachnoid hemorrhage

Risk calculators and risk factors for Subarachnoid hemorrhage pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

Pathophysiology

Aneurysmal subarachnoid hemorrhage

Aneurysmal subarachnoid hemorrhage is a result of :

  • Saccular aneurysms (responsible for most SAHs)
  • Fusiform aneurysms (dilatation of the entire circumference of the vessel that may in part be formed due to atherosclerosis)
  • Mycotic aneurysms  (infected emboli due to infective endocarditis)

Saccular aneurysms

Saccular (berry) aneurysms are responsible for most cases of subarachnoid hemorrhage (SAH). Multiple factors play a role in formation of a saccular aneurysms. Saccular aneurysms usually results from degenerative change in the vessel wall following:[1]

  • Hemodynamic stress (turbulent blood flow) which it may result in excessive tear and breakdown of the internal elastic lamina which it progress to lack of elastic lamina.

It is also thought that inflammatory process is also play a role in pathogenesis of aneurysms.[2]

Common associated conditions may include:[3][4][5]

The role for genetic factors in pathogenesis of aneurysmal formation has been approved. However, the exact pathogenesis remains unknown. It is thought that some connective tissue disease may result in arterial wall weakness and non-laminar flow pattern of blood, which is then progress to tear and breakdown of the wall.[4][5] Additionally, it is thought concurrent hypertension may play a role in patient with autosomal dominant polycystic kidney disease (PKD).[6]

Histopathologic findings

Unruptured aneurysms wall may present with complete absence of endothelial lining.

However, ruptured aneurysm walls may present with Inflammatory cells (T cell and macrophage infiltration) in addition to complete absence of endothelial lining.

Histological types of aneurysm walls may be identified as follow:[7]

Histological types Consecutive stages of aneurysm walls Chance of aneurysmal rupture
Type A
  • Endothelialized wall
  • Linearly organized smooth muscle cell
  • 41%
Type B
  • Thickened wall
  • Disorganized smooth muscle cells
  • 55%
Type C
  • 64%
Type D
  • Extremely thin thrombosis-lined hypocellular wall
  • 100%


Nonaneurysmal subarachnoid hemorrhage

References

  1. Austin G, Fisher S, Dickson D, Anderson D, Richardson S (1993). "The significance of the extracellular matrix in intracranial aneurysms". Ann Clin Lab Sci. 23 (2): 97–105. PMID 7681275.
  2. Aoki T, Nishimura M (2010). "Targeting chronic inflammation in cerebral aneurysms: focusing on NF-kappaB as a putative target of medical therapy". Expert Opin Ther Targets. 14 (3): 265–73. doi:10.1517/14728221003586836. PMID 20128708.
  3. Starke RM, Chalouhi N, Ali MS, Jabbour PM, Tjoumakaris SI, Gonzalez LF; et al. (2013). "The role of oxidative stress in cerebral aneurysm formation and rupture". Curr Neurovasc Res. 10 (3): 247–55. PMC 3845363. PMID 23713738.
  4. 4.0 4.1 Pepin M, Schwarze U, Superti-Furga A, Byers PH (2000). "Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type". N Engl J Med. 342 (10): 673–80. doi:10.1056/NEJM200003093421001. PMID 10706896.
  5. 5.0 5.1 Neil-Dwyer G, Bartlett JR, Nicholls AC, Narcisi P, Pope FM (1983). "Collagen deficiency and ruptured cerebral aneurysms. A clinical and biochemical study". J Neurosurg. 59 (1): 16–20. doi:10.3171/jns.1983.59.1.0016. PMID 6864273.
  6. Vlak MH, Algra A, Brandenburg R, Rinkel GJ (2011). "Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis". Lancet Neurol. 10 (7): 626–36. doi:10.1016/S1474-4422(11)70109-0. PMID 21641282.
  7. Frösen J, Piippo A, Paetau A, Kangasniemi M, Niemelä M, Hernesniemi J; et al. (2004). "Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: histological analysis of 24 unruptured and 42 ruptured cases". Stroke. 35 (10): 2287–93. doi:10.1161/01.STR.0000140636.30204.da. PMID 15322297.

Template:WH Template:WS